Standard

Анализ влияния циторедуктивных операций у больных с олигометастатическим раком почки в клинической практике. / Семенов, Дмитрий Владимирович; Орлова, Рашида Вахидовна; Широкорад, В. И.; Кострицкий, С.В.; Глузман, Марк Игоревич; Корнева, Ю. С. .

In: СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ, Vol. 23, No. 1, 22.03.2024, p. 53-62.

Research output: Contribution to journal › Article › peer-review

Harvard

Семенов, ДВ, Орлова, РВ, Широкорад, ВИ, Кострицкий, СВ, Глузман, МИ & Корнева, ЮС 2024, 'Анализ влияния циторедуктивных операций у больных с олигометастатическим раком почки в клинической практике.', СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ, vol. 23, no. 1, pp. 53-62. https://doi.org/10.21294/1814-4861-2024-23-1-53-62

APA

Семенов, Д. В., Орлова, Р. В., Широкорад, В. И., Кострицкий, С. В., Глузман, М. И., & Корнева, Ю. С. (2024). Анализ влияния циторедуктивных операций у больных с олигометастатическим раком почки в клинической практике. СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ, 23(1), 53-62. https://doi.org/10.21294/1814-4861-2024-23-1-53-62

Vancouver

Семенов ДВ, Орлова РВ, Широкорад ВИ, Кострицкий СВ, Глузман МИ, Корнева ЮС. Анализ влияния циторедуктивных операций у больных с олигометастатическим раком почки в клинической практике. СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ. 2024 Mar 22;23(1):53-62. https://doi.org/10.21294/1814-4861-2024-23-1-53-62

Author

Семенов, Дмитрий Владимирович ; Орлова, Рашида Вахидовна ; Широкорад, В. И. ; Кострицкий, С.В. ; Глузман, Марк Игоревич ; Корнева, Ю. С. . / Анализ влияния циторедуктивных операций у больных с олигометастатическим раком почки в клинической практике. In: СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ. 2024 ; Vol. 23, No. 1. pp. 53-62.

BibTeX

@article{499b51f86cc845d28ff3c17ffee0e386,
title = "Анализ влияния циторедуктивных операций у больных с олигометастатическим раком почки в клинической практике.",
abstract = "Cytoreductive nephrectomy (CN) and metastasectomy are justified in patients with oligometastatic renal cell carcinoma (RCC). Objective: to evaluate the impact of cytoreductive surgery on survival rates in patients with oligometastatic RCС. Material and Methods. We retrospectively analyzed the data of 342 patients with oligometastatic RCC, who underwent systemic therapy and different types of cytoreductive surgeries at the Municipal Oncology Hospital No. 62 in Moscow and the Municipal Oncoloy Center in Saint Petersburg from 2006 to 2022. Cytoreductive nephrectomy was performed in 332 (97.1 %) patients, metastasectomy in 103 (30.1 %) patients. The survival rates of patients in treatment groups were evaluated using the Survival Analysis by calculating descriptive characteristics of survival time by means of a life-table and Kaplan–Meier curves. The results were considered statistically significant at p",
keywords = "cytoreductive nephrectomy, metastasectomy, oligometastatic renal cell cancer",
author = "Семенов, {Дмитрий Владимирович} and Орлова, {Рашида Вахидовна} and Широкорад, {В. И.} and С.В. Кострицкий and Глузман, {Марк Игоревич} and Корнева, {Ю. С.}",
year = "2024",
month = mar,
day = "22",
doi = "10.21294/1814-4861-2024-23-1-53-62",
language = "русский",
volume = "23",
pages = "53--62",
journal = "СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ",
issn = "1814-4861",
publisher = "Томский национальный исследовательский медицинский центр Российской академии наук",
number = "1",

}

RIS

TY - JOUR

T1 - Анализ влияния циторедуктивных операций у больных с олигометастатическим раком почки в клинической практике.

AU - Семенов, Дмитрий Владимирович

AU - Орлова, Рашида Вахидовна

AU - Широкорад, В. И.

AU - Кострицкий, С.В.

AU - Глузман, Марк Игоревич

AU - Корнева, Ю. С.

PY - 2024/3/22

Y1 - 2024/3/22

N2 - Cytoreductive nephrectomy (CN) and metastasectomy are justified in patients with oligometastatic renal cell carcinoma (RCC). Objective: to evaluate the impact of cytoreductive surgery on survival rates in patients with oligometastatic RCС. Material and Methods. We retrospectively analyzed the data of 342 patients with oligometastatic RCC, who underwent systemic therapy and different types of cytoreductive surgeries at the Municipal Oncology Hospital No. 62 in Moscow and the Municipal Oncoloy Center in Saint Petersburg from 2006 to 2022. Cytoreductive nephrectomy was performed in 332 (97.1 %) patients, metastasectomy in 103 (30.1 %) patients. The survival rates of patients in treatment groups were evaluated using the Survival Analysis by calculating descriptive characteristics of survival time by means of a life-table and Kaplan–Meier curves. The results were considered statistically significant at p

AB - Cytoreductive nephrectomy (CN) and metastasectomy are justified in patients with oligometastatic renal cell carcinoma (RCC). Objective: to evaluate the impact of cytoreductive surgery on survival rates in patients with oligometastatic RCС. Material and Methods. We retrospectively analyzed the data of 342 patients with oligometastatic RCC, who underwent systemic therapy and different types of cytoreductive surgeries at the Municipal Oncology Hospital No. 62 in Moscow and the Municipal Oncoloy Center in Saint Petersburg from 2006 to 2022. Cytoreductive nephrectomy was performed in 332 (97.1 %) patients, metastasectomy in 103 (30.1 %) patients. The survival rates of patients in treatment groups were evaluated using the Survival Analysis by calculating descriptive characteristics of survival time by means of a life-table and Kaplan–Meier curves. The results were considered statistically significant at p

KW - cytoreductive nephrectomy

KW - metastasectomy

KW - oligometastatic renal cell cancer

UR - https://www.mendeley.com/catalogue/13f3d7f8-db73-323b-934e-0b635411ab84/

U2 - 10.21294/1814-4861-2024-23-1-53-62

DO - 10.21294/1814-4861-2024-23-1-53-62

M3 - статья

VL - 23

SP - 53

EP - 62

JO - СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ

JF - СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ

SN - 1814-4861

IS - 1

ER -

ID: 124182359